Categories: News

VVDN Acquires GGS Engineering, Expanding its ER&D Portfolio in Automotive, MedTech and Aerospace Industries

GURUGRAM, India, Aug. 18, 2025 /PRNewswire/ — VVDN Technologies, a global provider of software, product engineering and electronics manufacturing services & solutions, today announced the acquisition of GGS Engineering Services, a leading engineering solutions company specializing in offering enhanced ER&D services for the Automotive, MedTech and Aerospace industries. 

- Advertisement -

With this acquisition, VVDN has onboarded engineers with two decades of experience in Mechanical Design, Analysis, Simulation, Virtual Manufacturing and Technical Publications.

- Advertisement -

The key benefits of this acquisition for OEMs include:

- Advertisement -
  • Innovative Product Development with Accelerated Time-to-Market.
  • Value Added Engineering for Cost Optimization.
  • Scalable Engineering Talent Solutions.

The integration of GGS Engineering’s mechanical and electrical expertise with VVDN’s embedded systems and manufacturing prowess creates a unique vertically integrated solution for OEMs across key industries such as:

- Advertisement -
  • Automotive: GGS enables OEMs to create innovative designs that meet modern consumer expectations. VVDN now will be addressing the sector’s rapidly evolving needs for cabin designs, vehicle electrification, NVH (Noise, Vibration, Harshness) refinement, and cutting-edge styling and wire harness.
  • MedTech: VVDN will be serving MedTech customers with added portfolio by supporting them in the development of customized, precise, and efficient medical devices, implants, and surgical tools
  • Aerospace: Combined with GGS experience in CAD/CAM skillset, VVDN will be able to support OEMs and Tier 1s to design and manufacture complex aircraft components with precision and efficiency.

Together, VVDN & GGS set the stage for smarter machines, faster development, and stronger competitive advantages across industries. The combined entity will operate under the VVDN umbrella, with GGS’ leadership and founding teams continuing to play a pivotal role in the business.

- Advertisement -

Puneet Agarwal, CEO – VVDN Technologies: “We are delighted to welcome GGS Engineering Services into the VVDN family. Their proven excellence in mechanical engineering and design significantly enhances our value proposition to global clients. Our strengthened expertise now allows us to deliver comprehensive, cost-optimized product development for the automotive, medical, and aerospace industries—positioning VVDN to expand its footprint in automotive ER&D space. We look forward to working together to deliver accelerated innovation and end-to-end engineering leadership.”

- Advertisement -

This acquisition is a crucial step in VVDN’s growth strategy, enabling the company to aggressively penetrate the multi-billion-dollar global ER&D market and unlock new revenue opportunities across high-growth verticals.

- Advertisement -

Logo: https://mma.prnewswire.com/media/1531036/3360584/VVDN_Technologies_Logo.jpg

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.com/in/news-releases/vvdn-acquires-ggs-engineering-expanding-its-erd-portfolio-in-automotive-medtech-and-aerospace-industries-302529028.html

- Advertisement -

Recent Posts

Hexaware Expands Presence in Gujarat with New Delivery Center at GIFT City

MUMBAI, India, LONDON and ISELIN, N.J., June 13, 2026 /PRNewswire/ -- Hexaware Technologies [NSE: HEXT], a…

1 hour ago

Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026

 -- Patients with PWS treated with setmelanotide therapy (N=17) achieved clinically meaningful BMI or BMI…

2 hours ago

Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema

June 13, 2026 07:30 ET  | Source: Intellia Therapeutics, Inc. Data from HAELO Phase 3…

2 hours ago

New TALVEY(talquetamab) plus daratumumab data demonstrate the potential strength of a novel bispecific combination in earlier-line relapsed or refractory multiple myeloma

TALVEY® plus daratumumab with or without pomalidomide showed progression-free survival of up to 81.3% and overall survival of…

2 hours ago

President Droupadi Murmu Confers Kirti Chakra on Chandigarh University Alumnus Major Arshdeep Singh Gill

"Chandigarh University not only provides quality education but also instills a spirit of patriotism," says…

4 hours ago

Bitmine Immersion Technologies Announces Initial Dividends and NYSE Listing for Series A Preferred Stock

Bitmine's Board of Directors declares initial cash dividends on the Company's 9.50% Series A Perpetual…

6 hours ago